Skip to Content

APO MYC500 (Mycophenolate mofetil 500 mg)

Pill imprint APO MYC500 has been identified as Mycophenolate mofetil 500 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; dermatomyositis; autoimmune hepatitis; organ transplant, rejection prophylaxis; cogan's syndrome (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil 500 mg APO MYC500
Mycophenolate mofetil 500 mg APO MYC500
Discount Card Promo
Mycophenolate mofetil
Imprint:
APO MYC500
Strength:
500 mg
Color:
Purple
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-2967
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
ferric oxide red
titanium dioxide
ferrosoferric oxide
microcrystalline cellulose
silicon dioxide
hypromelloses
hydroxypropyl cellulose
propylene glycol
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0588 Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide